上海家化(600315) - 2022 Q4 - 年度财报

Financial Performance - Total operating revenue for 2022 was CNY 7,106,312,871.72, a decrease of 7.06% from CNY 7,646,123,006.52 in 2021[25] - Total operating costs for 2022 were CNY 6,525,610,183.17, down 8.46% from CNY 7,127,732,058.27 in 2021[25] - Net profit for 2022 was CNY 472,039,277.83, a decline of 27.36% compared to CNY 649,251,942.17 in 2021[26] - Comprehensive income for 2022 totaled CNY 181,022,607.44, significantly lower than CNY 521,602,072.13 in 2021[28] - The company reported a total profit of CNY 548,883,199.60 for 2022, down from CNY 764,341,580.23 in 2021[26] - The company reported a net loss attributable to shareholders of 135,413,235.89 RMB for the year 2022[36] - The total comprehensive income for 2022 was approximately ¥521.60 million[96] - The company reported a profit distribution of approximately -¥135.41 million, indicating a significant loss allocation to shareholders[96] Shareholder Information - The number of ordinary shareholders increased to 45,017 by the end of the reporting period, up from 42,897 at the end of the previous month[1] - The company had no preferred shareholders with restored voting rights as of the end of the reporting period[1] - The total issued share capital of the company as of December 31, 2022, is 678,873,194 shares, with a par value of 1.00 yuan per share, totaling 678,873,194.00 yuan[72] Cash Flow and Liquidity - Cash and cash equivalents at the end of 2022 were CNY 1,675,679,218.94, an increase from CNY 1,587,764,038.66 at the beginning of the year[30] - The company experienced a net cash outflow from financing activities of CNY 383,835,499.08 in 2022, compared to an outflow of CNY 228,370,607.91 in 2021[30] - The cash received from investment decreased by 31.04% year-on-year, amounting to 3,322,618,517.50 yuan compared to 4,818,036,407.64 yuan in the previous period[78] - The cash received from investment income increased by 69.69% year-on-year, reaching 209,293,850.37 yuan, up from 123,337,316.85 yuan[78] - The cash paid for dividends and interest increased by 40.96% year-on-year, totaling 234,241,987.20 yuan compared to 166,182,044.96 yuan in the previous period[78] - The cash received from financing activities decreased by 74.41% year-on-year, amounting to 12,081,400.00 yuan compared to 47,219,400.00 yuan[78] Assets and Liabilities - The total current assets increased from ¥1,597,254,055.90 in 2021 to ¥1,685,169,236.18 in 2022, reflecting a growth of approximately 5.5%[55] - The total current liabilities rose from ¥3,209,752,725.54 in 2021 to ¥3,533,228,648.26 in 2022, indicating an increase of about 10.1%[56] - The company's total liabilities decreased from ¥5,182,234,320.45 in 2021 to ¥5,020,001,233.87 in 2022, a reduction of approximately 3.1%[56] - The total equity attributable to shareholders increased from ¥6,963,277,401.62 in 2021 to ¥7,249,484,579.10 in 2022, representing a growth of about 4.1%[56] - The company's inventory rose from ¥872,052,322.43 in 2021 to ¥928,956,162.53 in 2022, reflecting an increase of about 6.5%[55] - The long-term borrowings decreased from ¥925,188,000.00 in 2021 to ¥751,271,950.00 in 2022, a decline of approximately 18.8%[56] - The deferred income tax liabilities decreased from ¥123,308,270.77 in 2021 to ¥114,340,214.64 in 2022, a reduction of about 7.3%[56] - The total equity attributable to the parent company at the end of 2022 was 6,499,224,054.26 RMB, with a decrease of 195,196,626.49 RMB compared to the previous year[34] - The company's total equity at the end of 2022 was approximately ¥7.96 billion, reflecting a slight decrease from ¥7.96 billion at the end of 2021[69] Research and Development - Research and development expenses for 2022 were CNY 159,892,218.26, slightly down from CNY 163,127,112.92 in 2021[26] - The company is engaged in the development, production, and sales of cosmetics and daily chemical products, indicating a focus on market expansion in these sectors[97] - The company is focused on enhancing its product offerings and expanding its market presence through new product development and strategic initiatives[97] Strategic Initiatives - The company aims for a double-digit revenue growth in 2023 compared to 2022, driven by consumer-centered strategies and brand innovation[85] - The company plans to enhance its brand through collaborations with industry experts and marketing strategies, focusing on personalized consumer needs[85] - The company will continue to develop its e-commerce channels, emphasizing refined operations and cross-brand user engagement[85] - The company will focus on enhancing its offline retail channels and improving customer service experiences in 2023[85] - The company will optimize processes and data through digital transformation to improve efficiency in marketing and supply chain[85] Accounting Policies and Estimates - The company’s financial statements are prepared based on specific accounting policies and estimates, including the measurement of expected credit losses on receivables and inventory valuation methods[43] - The company’s accounting year runs from January 1 to December 31[44] - The company conducts impairment testing for assets at least annually, especially for goodwill and intangible assets with indefinite useful lives[168] - The group recognizes expected credit losses based on the risk of default, calculating the present value of the difference between cash flows expected to be received and actual cash flows[175] - The group classifies receivables into several portfolios based on credit risk characteristics to calculate expected credit losses, including bank acceptance bills and receivables from customers classified by credit rating[178] Audit and Compliance - The company has identified key audit matters that are critical to the financial statements, emphasizing the importance of these matters in the overall audit process[46] - The financial statements were approved by the board on April 24, 2023, and will be submitted for shareholder review[98]